文献速递血液净化与透析肾移植

医疗补助扩展与终末期肾病初始治疗优化相关

Medicaid Expansion and Optimal Starts of Treatment for Incident Kidney Failure.
PubMed 文献 · Am J Kidney Dis · 2026-03-20

本研究基于美国肾脏数据系统2008-2019年26-64岁新发肾衰竭患者,采用中断时间序列分析,比较2014年医疗补助扩展州与非扩展州在优化起始治疗(抢先移植、起始家庭透析或使用动静脉通路的中心血透)比例的趋势差异。结果显示扩展州该比例持续上升而非扩展州下降,至2019年差异达3.9%(95%CI 0.5%-7.2%),主要归因于家庭透析使用的增加。

要点

  • 医疗补助扩展州终末期肾病患者优化起始治疗比例较非扩展州高3.9%。
  • 差异主要源于扩展州家庭透析使用率的更大增长。
  • 扩展医疗补助可能改善低收入肾衰竭患者的初始治疗。

核心结论

  • 医疗补助扩展与终末期肾病患者优化起始治疗比例增加相关,主要由家庭透析使用增加驱动。

研究设计与样本

  • 观察性队列研究,纳入美国肾脏数据系统中2008-2019年26-64岁新发肾衰竭患者。
  • 采用中断时间序列分析,比较扩展州与非扩展州在2014年医疗补助扩展前后的趋势变化。

主要发现

  • 扩展前,扩展州与非扩展州优化起始治疗比例增长趋势相似。
  • 扩展后,扩展州优化起始治疗比例继续上升而非扩展州下降,至2019年差异为3.9%(95%CI 0.5%-7.2%),趋势变化P=0.02。
  • 差异主要归因于扩展州家庭透析使用增加更明显(每年差异0.29%,95%CI 0.08%-0.51%)。

关键数值与推荐

  • 优化起始治疗定义为:抢先肾移植、起始家庭透析或使用动静脉通路起始中心血透。

临床怎么用

  • 扩展医疗补助可能为改善低收入终末期肾病患者初始治疗提供机会。

局限性

  • 可能存在来自医疗补助扩展以外州级因素的未测量混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Beginning in 2014, some states expanded Medicaid eligibility to include additional low-income adults under the age of 65 years. Examining whether the expansion led to improvements in optimal treatment at the start of kidney failure has been understudied and was the focus of this investigation. STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: Patients aged 26-64 years represented in the US Renal Data System initiating treatment for kidney failure between 2008 and 2019. EXPOSURE: Residence in states that did or did not expand Medicaid in 2014. OUTCOME: An optimal start of kidney failure treatment was defined as undergoing preemptive kidney transplant, initiating home dialysis, or initiating in-center hemodialysis using an arteriovenous access. ANALYTICAL APPROACH: Interrupted time-series analyses were implemented to evaluate the adjusted association of residence in a Medicaid-expansion state and optimal kidney failure treatment by comparing the trend in optimal kidney failure treatment starts during the preexpansion period versus the postexpansion period. RESULTS: Before Medicaid expansion, the percentage of patients with optimal starts increased similarly in expansion and nonexpansion states. After Medicaid expansion, the percentage with optimal starts continued to increase in expansion states but decreased in nonexpansion states, resulting in a 3.9% (95% CI, 0.5%-7.2%) higher percentage with optimal starts in expansion versus nonexpansion states by 2019 (postexpansion vs preexpansion change in trend, P = 0.02). Most of the change in trend was attributable to a greater increase in use of home dialysis at initiation of kidney failure treatment in expansion versus nonexpansion states (difference of 0.29% per year; 95% CI, 0.08%-0.51%) during the postexpansion period. LIMITATIONS: Potential for unmeasured confounding from state-level factors other than Medicaid expansion. CONCLUSIONS: Medicaid expansion was associated with an increasing percentage of patients with incident kidney failure experiencing an optimal start to treatment, driven mostly by an increase in the use of home dialysis. Expanding Medicaid coverage may offer an opportunity to improve treatment for low-income patients initiating kidney replacement therapy. PLAIN-LANGUAGE SUMMARY: This study examined whether the expansion of Medicaid eligibility in 2014 led to improvements in the percentage of patients receiving an optimal start to treatment for new-onset kidney failure (ie, kidney transplant before the need to start dialysis, initiation of home dialysis, or initiation of in-center hemodialysis using an arteriovenous access). We compared trends from 2008 to 2019 across US states that expanded Medicaid and those that did not. Before 2014, both groups showed a similar upward trend in optimal starts. However, after Medicaid expansion, states that expanded Medicaid continued to experience an increase in optimal starts whereas states that did not expand showed a decrease over time. Much of the difference was explained by a larger increase in the use of home dialysis in states that expanded access to Medicaid. Our findings suggest that expanding Medicaid may lead to better initial treatment for kidney failure.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Roetker NS, Wetmore JB, Liu J, et al. Medicaid Expansion and Optimal Starts of Treatment for Incident Kidney Failure. Am J Kidney Dis. 2026. PMID: 41866017. doi:10.1053/j.ajkd.2026.01.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。